3 Cancer Treatment Stocks to Buy Right Now
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.
Iovance Biotherapeutics, Inc.
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.
Good news from the biotech's mid-stage clinical study is exciting investors.
IOVA earnings call for the period ending September 30, 2019.
The company is flush with cash and wields a promising therapeutic pipeline. Is its recent tumble a buying opportunity?
IOVA earnings call for the period ending June 30, 2019.
These three biotech stocks might be outstanding buys right now.
The clinical-stage biopharma announced promising data at a major conference.
These three healthcare stocks could be outstanding additions to your portfolio.
Pfizer's acquisition of Array appeared to cause investors to wonder whether a big deal could be in store for Iovance.
Could the second half of the year be as much fun as the first?